Merck Q2 results hit by Glucophage competition
Second quarter results at Merck, the German pharmaceutical group, were impacted by competition from generic versions of its top-selling product, the anti-diabetes drug Glucophage.
News, Analysis & Insights on Nutrition, Supplements, and Health
Second quarter results at Merck, the German pharmaceutical group, were impacted by competition from generic versions of its top-selling product, the anti-diabetes drug Glucophage.
Naturol, the US company which develops technology to extract oils and other compounds from plants, has been bought by Canada's Coronado group.
A major study of the effects of hormone replacement therapy has been halted after scientists discovered a major risk of ovarian cancer - but there are plenty of natural alternatives to help women deal with the menopause.
Vitamin supplement maker and marketer is hit by poor results from several international markets, but still sees light at the end of the tunnel.
The US Food & Drug Administration is reconsidering its advice about whether or not tuna fish is safe for pregnant women after its earlier recommendation that a few servings of most fish are safe was criticised for bowing to pressure from the seafish...